Site of effect of LY2951742 for migraine prophylaxis–Authors' reply

DWD has served on advisory boards or consulted for Allergan, Amgen, Alder, Arteaus Therapeutics, Pfizer, Boston Scientific, Medtronic, St Jude, Bristol-Myers Squibb, Lundbeck, Impax, MAP, Electrocore, Colucid, Merck, ENeura, NuPathe, Eli Lilly, Autonomic Technologies, Ethicon Johnson and Johnson, Zo...

Full description

Saved in:
Bibliographic Details
Published in:Lancet neurology 2015, Vol.14 (1), p.32-33
Main Authors: Dodick, David W, Goadsby, Peter J, Spierings, Egilius L H, Scherer, Joel C, Sweeney, Steven P, Grayzel, David S
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal, Humanized - pharmacology
Blood-brain barrier
Calcitonin Gene-Related Peptide - antagonists & inhibitors
Consultants
Drug therapy
Female
Humans
Male
Manycompanies
Migraine
Migraine Disorders - prevention & control
Neurology
Pharmaceutical industry
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:DWD has served on advisory boards or consulted for Allergan, Amgen, Alder, Arteaus Therapeutics, Pfizer, Boston Scientific, Medtronic, St Jude, Bristol-Myers Squibb, Lundbeck, Impax, MAP, Electrocore, Colucid, Merck, ENeura, NuPathe, Eli Lilly, Autonomic Technologies, Ethicon Johnson and Johnson, Zogenix, Supernus, and Labrys; has received funding for travel, speaking, or editorial activities, or royalty payments from IntraMed, SAGE Publishing, Sun Pharma, Allergan, Oxford University Press, American Academy of Neurology, West Virginia University Foundation, Canadian Headache Society, Healthlogix, Wiley, Universal Meeting Management, WebMD, UptoDate, Oregon Health Science Center, Starr Clinical, Decision Resources, and Synergy.
ISSN:1474-4422
1474-4465
DOI:10.1016/S1474-4422(14)70309-6